These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23314044)

  • 41. Prevalence and 25 year incidence of proliferative retinopathy among Danish type 1 diabetic patients.
    Grauslund J; Green A; Sjølie AK
    Diabetologia; 2009 Sep; 52(9):1829-35. PubMed ID: 19593541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
    Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II
    Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What may be gained from standard photocoagulation during early worsening of diabetic retinopathy? An observational study in type-1 diabetic patients after tightening of glycaemic control.
    Chantelau E
    Diabetes Metab; 2001 Jun; 27(3):366-71. PubMed ID: 11431602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipid-Lowering Medications Are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among United States Patients with Diabetes.
    Vail D; Callaway NF; Ludwig CA; Saroj N; Moshfeghi DM
    Am J Ophthalmol; 2019 Nov; 207():378-384. PubMed ID: 31194953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of HbA1c Followed 32 Years From Diagnosis of Type 1 Diabetes on Development of Severe Retinopathy and Nephropathy: The VISS Study.
    Arnqvist HJ; Westerlund MC; Fredrikson M; Ludvigsson J; Nordwall M
    Diabetes Care; 2022 Nov; 45(11):2675-2682. PubMed ID: 36094113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Visit-to-visit systolic blood pressure variability and microvascular complications among patients with diabetes.
    Sohn MW; Epstein N; Huang ES; Huo Z; Emanuele N; Stukenborg G; Guihan M; Li J; Budiman-Mak E
    J Diabetes Complications; 2017 Jan; 31(1):195-201. PubMed ID: 27671535
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.
    Luk AO; Ma RC; Lau ES; Yang X; Lau WW; Yu LW; Chow FC; Chan JC; So WY
    Diabetes Metab Res Rev; 2013 Jul; 29(5):384-90. PubMed ID: 23463747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prevalence of the Diabetic Retinopathy and Genetic Factors Significance in the Development of Diabetic Retinopathy in Patients with Diabetes Mellitus type I and II in Slovakia (DIARET SK study). Overview of Actual Findings and Design of the Epidemiological DIARET SK Study].
    Krásnik V; Štefaničková J; Fabková J; Bucková D; Helbich M
    Cesk Slov Oftalmol; 2015 Sep; 71(5):237-42. PubMed ID: 26782726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening eye exams in youth with type 1 diabetes under 18 years of age: Once may be enough?
    Gubitosi-Klug RA; Bebu I; White NH; Malone J; Miller R; Lorenzi GM; Hainsworth DP; Trapani VR; Lachin JM; Tamborlane WV;
    Pediatr Diabetes; 2019 Sep; 20(6):743-749. PubMed ID: 31206973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Possible Modifying Effect of Hemoglobin A1c on Genetic Susceptibility to Severe Diabetic Retinopathy in Patients With Type 2 Diabetes.
    Ng KKK; Cheung CYY; Lee CH; Fong CHY; Kwok KHM; Li KKW; Gangwani RA; Wong IYH; Woo YC; Chow WS; Yuen MMA; Wong RLC; Xu A; Wong DSH; Sham PC; Lam KSL
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):7. PubMed ID: 32756921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ketoacidosis at diagnosis in childhood-onset diabetes and the risk of retinopathy 20years later.
    Salardi S; Porta M; Maltoni G; Cerutti F; Rovere S; Iafusco D; Tumini S; Cauvin V; Zucchini S; Cadario F; dʾAnnunzio G; Toni S; Salvatoni A; Zedda MA; Schiaffini R;
    J Diabetes Complications; 2016; 30(1):55-60. PubMed ID: 26598223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Hainsworth DP; Gao X; Bebu I; Das A; Olmos de Koo L; Barkmeier AJ; Tamborlane W; Lachin JM; Aiello LP;
    Ophthalmology; 2021 Apr; 128(4):554-560. PubMed ID: 32941962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up.
    Pongrac Barlovic D; Harjutsalo V; Gordin D; Kallio M; Forsblom C; King G; Groop PH;
    Diabetes Care; 2018 Dec; 41(12):2487-2494. PubMed ID: 30257963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence and Risk for Developing Proliferative Diabetic Retinopathy after Photocoagulation for Diabetic Maculopathy.
    Bek T
    Curr Eye Res; 2020 Aug; 45(8):986-991. PubMed ID: 31920110
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The temporal development of retinopathy and nephropathy in type 1 diabetes mellitus during 15 years diabetes duration.
    Lövestam-Adrian M; Agardh E; Agardh CD
    Diabetes Res Clin Pract; 1999 Aug; 45(1):15-23. PubMed ID: 10499881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 2 diabetes mellitus.
    Chetthakul T; Deerochanawong C; Suwanwalaikorn S; Kosachunhanun N; Ngarmukos C; Rawdaree P; Krittiyawong S; Leelawatana R; Bunnag P; Plengvidhya N; Pratipanawatr T; Benjasuratwong Y; Mongkolsomlit S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S27-36. PubMed ID: 17715831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
    Yang CY; Su PF; Hung JY; Ou HT; Kuo S
    Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.
    Stratton IM; Kohner EM; Aldington SJ; Turner RC; Holman RR; Manley SE; Matthews DR
    Diabetologia; 2001 Feb; 44(2):156-63. PubMed ID: 11270671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxidized Low-Density Lipoprotein and the Incidence of Proliferative Diabetic Retinopathy and Clinically Significant Macular Edema Determined From Fundus Photographs.
    Klein R; Myers CE; Lee KE; Paterson AD; Cruickshanks KJ; Tsai MY; Gangnon RE; Klein BE
    JAMA Ophthalmol; 2015 Sep; 133(9):1054-61. PubMed ID: 26181138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.